ASCEND Study of Natalizumab Efficacy on Disability in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Baseline Demographics and Disease Characteristics

被引：0
|
作者：
Mikol, Daniel
Freedman, Mark S.
Goldman, Myla D.
Hartung, Hans-Peter
Havrdova, Eva
Jeffery, Douglas
Kapoor, Raj
Miller, Aaron
Sellebjerg, Finn
Lee, Sophia
Chen, Yun
Cadavid, Diego
Ticho, Barry
机构：
来源：
ANNALS OF NEUROLOGY | 2013年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [11] Comparative study of the IFN-b1b efficacy in secondary progressive multiple sclerosis (SPMS)
    Sokolova, L. I.
    Kobys, T. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 129 - 129
  • [12] Effect of natalizumab in patients with progressive forms of multiple sclerosis and high disability
    Petrou, P.
    Vaknin-Dembinsky, A.
    Abramsky, O.
    Ben-Hur, T.
    Karussis, D.
    JOURNAL OF NEUROLOGY, 2011, 258 : 255 - 255
  • [13] Subgroup analyses of natalizumab treatment response in ASCEND, a multicenter, double-blind, placebo-controlled, randomized phase 3 clinical trial in patients with secondary progressive multiple sclerosis (SPMS).
    Kapoor, R.
    Steiner, D.
    Miller, A.
    Giovannoni, G.
    Cohan, S.
    Gold, R.
    Rog, D.
    Ho, P. -R.
    Elkins, J.
    Li, H.
    Amarante, D.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 874 - 875
  • [14] Natalizumab versus placebo in patients with secondary progressive multiple sclerosis (SPMS): Results from ASCEND, a multicenter, double-blind, placebo-controlled, randomized phase 3 clinical trial
    Steiner, Deborah
    Arnold, Douglas
    Freedman, Mark
    Goldman, Myla
    Hartung, Hans-Peter
    Havrdova, Eva
    Jeffery, Douglas
    Kapoor, Raj
    Miller, Aaron
    Sellebjerg, Finn
    Amarante, Diogo
    Cadavid, Diego
    Yu, Bei
    Forrestal, Fiona
    Liu, Kezhen
    NEUROLOGY, 2016, 87 (02) : E22 - E22
  • [15] The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study
    Fernandez, Oscar
    Papais Alvarenga, Marcos
    Guerrero, Miguel
    Leon, Antonio
    Alonso, Ana
    Carlos Lopez-Madrona, Jose
    Leyva, Laura
    Oliver, Begona
    de Ramon, Enrique
    Luque, Gloria
    Fernandez, Victoria
    MULTIPLE SCLEROSIS, 2011, 17 (02): : 192 - 197
  • [16] Development of a screening tool to support identification of patients with secondary progressive multiple sclerosis (SPMS)
    Ziemssen, T.
    Simsek, D.
    Lahoz, R.
    Verdun, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 621 - 621
  • [17] Monitoring cognition in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients
    White, J.
    Gabriele, S.
    Lin, D.
    Vindici, J.
    Teoh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 214 - 214
  • [18] Baseline Demographics and Disease Characteristics from ORATORIO, a Phase III Trial Evaluating Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
    Montalban, X.
    Hemmer, B.
    Rammohan, K.
    Giovannoni, G.
    de Seze, J.
    Bar-Or, A.
    Arnold, D.
    Sauter, A.
    Leppert, D.
    Chin, P.
    Garren, H.
    Messier, M.
    Wolinski, J.
    Kakarieka, A.
    Masterman, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 706 - 706
  • [19] DEVELOPMENT OF A SCREENING TOOL TO SUPPORT IDENTIFICATION OF PATIENTS WITH SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
    Ziemssen, T.
    Simsek, D.
    Lahoz, R.
    Verdun di Cantogno, E.
    VALUE IN HEALTH, 2015, 18 (07) : A763 - A763
  • [20] Assessment of disease progression in patients with secondary progressive multiple sclerosis (SPMS) using a novel functional composite endpoint
    Kappos, L.
    Vermersch, P.
    Cree, B.
    Benedict, R.
    Giovannoni, G.
    Bar-or, A.
    Gold, R.
    Arnould, S.
    Rouyrre, N.
    Karlsson, G.
    Piani-Meier, D.
    Dahlke, F.
    Wolf, C.
    Tomic, D.
    Fox, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 240 - 241
12345